Therapy of estrogen-associated disorders
CA 2325631 A1 · Owner: Kelly, Graham Edmund · Inventors: Kelly, Graham Edmund; Husband, Alan James
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for the treatment, prophylaxis amelioration or prevention of , disorders associated with abnormally high activity of steroidal estrogens which includes administering to a human subject a composition comprising an isoflavone-containing extract of clover or chick peas said extract comprising , primarily biochanin or a ratio of biochanin to one or more of the isoflavones from the group formononetin, daidzein and genistein in the range of from about 2:1 to about 5:1, optionally in association with one or more pharmaceutically acceptable carriers, excipients, auxiliaries and/or diluents is described. Also described are compositions and uses comprising the isoflavone containing …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 26, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 26, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 26, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.